Annexon (ANNX) Total Current Liabilities (2019 - 2026)
Annexon (ANNX) posted quarterly Total Current Liabilities of $35.9 million for Q1 2026, up 7.12% year-over-year from $33.5 million in Q1 2025, and down 15.7% quarter-over-quarter from $42.6 million in Q4 2025.
Analysis
Annexon (ANNX) Total Current Liabilities (2019 - 2026) Analysis & Trends
Annexon's Total Current Liabilities history runs 8 years deep, the most recent figure standing at $35.9 million for Q1 2026.
- In Q1 2026, Total Current Liabilities rose 7.12% year-over-year to $35.9 million; the TTM figure through Mar 2026 stood at $35.9 million (up 7.12% YoY), while the FY2025 annual figure was $42.6 million, up 39.72% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $35.9 million, down from $42.6 million in the prior quarter.
- The five-year high for Total Current Liabilities was $43.6 million in Q3 2025, with the low at $13.1 million in Q1 2024.
- The 5-year median for Total Current Liabilities is $20.3 million (2022), against an average of $25.5 million.
- The sharpest annual moves came in 2024 and 2025: Total Current Liabilities sank 42.75% in 2024, then soared 155.44% in 2025.
- Annexon's Total Current Liabilities stood at $22.4 million in 2022, then fell by 19.82% to $17.9 million in 2023, then jumped by 70.19% to $30.5 million in 2024, then surged by 39.72% to $42.6 million in 2025, then dropped by 15.7% to $35.9 million in 2026.
- Business Quant data shows ANNX's Total Current Liabilities at $35.9 million in Q1 2026, $42.6 million in Q4 2025, and $43.6 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 2.53 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 354.06 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.51 Bn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 630.93 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Annexon | 982.93 Mn | 982.93 Mn | - | 38.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 38.48 Mn |
| Mar 31, 2026 | 35.94 Mn |
| Dec 31, 2025 | 42.63 Mn |
| Sep 30, 2025 | 43.58 Mn |
| Jun 30, 2025 | 40.64 Mn |
| Mar 31, 2025 | 33.55 Mn |
| Dec 31, 2024 | 30.51 Mn |
| Sep 30, 2024 | 20.05 Mn |
| Jun 30, 2024 | 17.15 Mn |
| Mar 31, 2024 | 13.13 Mn |
| Dec 31, 2023 | 17.93 Mn |
| Sep 30, 2023 | 17.17 Mn |
| Jun 30, 2023 | 17.89 Mn |
| Mar 31, 2023 | 22.94 Mn |
| Dec 31, 2022 | 22.36 Mn |
| Sep 30, 2022 | 20.22 Mn |
| Jun 30, 2022 | 20.25 Mn |
| Mar 31, 2022 | 17.05 Mn |
| Dec 31, 2021 | 21.74 Mn |
| Sep 30, 2021 | 11.92 Mn |